Severe Lymphopenia as a Predictor of COVID-19 Mortality in Immunosuppressed Patients

Background. Coronavirus disease 2019 (COVID-19) has a high mortality in certain group of patients. We analysed the impact of baseline immunosuppression in COVID-19 mortality and the role of severe lymphopenia in immunocompromised subjects. Methods. We analysed all patients admitted with COVID-19 in...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical medicine 2021-08, Vol.10 (16), p.3595
Main Authors: Martínez-Urbistondo, María, Gutiérrez-Rojas, Ángela, Andrés, Ane, Gutiérrez, Isabel, Escudero, Gabriela, García, Sonia, Gutiérrez, Andrea, Sánchez, Enrique, Herráiz, Jesús, De La Fuente, Sara, Callejas, Alejandro, De Mendoza, Carmen, Moreno-Torres, Víctor
Format: Article
Language:English
Subjects:
Autoimmune diseases
Blood diseases
Cardiovascular disease
Chemotherapy
Clinical medicine
Coronaviruses
COVID-19
Cytokine storm
Infections
Kidney diseases
Lymphocytes
Medical records
Mortality
Multivariate analysis
Pandemics
Pneumonia
Population
Risk factors
Severe acute respiratory syndrome coronavirus 2
Statistical analysis
Steroids
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background. Coronavirus disease 2019 (COVID-19) has a high mortality in certain group of patients. We analysed the impact of baseline immunosuppression in COVID-19 mortality and the role of severe lymphopenia in immunocompromised subjects. Methods. We analysed all patients admitted with COVID-19 in a tertiary hospital in Madrid between March 1st and April 30th 2020. Epidemiological and clinical data, including severe lymphopenia (
ISSN:2077-0383
2077-0383
DOI:10.3390/jcm10163595